Epigenomics companies study chemical and structural changes that regulate gene activity without altering the underlying DNA sequence. Their technologies support biological research, biomarker discovery, diagnostics and the development of therapies targeting epigenetic mechanisms.
This category includes companies working on:
Browse 26 UK epigenomics companies below.
3D genomics platform for blood-based clinical diagnostics and precision medicine
Oxford BioDynamics develops blood-based diagnostic tests and precision medicine tools using its proprietary 3D genomics platform. The technology analyses chromosome conformation…
Bioinformatics CRO delivering omics data analysis and interpretation
Fios Genomics is an Edinburgh-based bioinformatics contract research organisation providing data analysis and interpretation services across genomics, transcriptomics, proteomics…
3D multi-omics platform for genetically validated drug target discovery
Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug…
First-in-class small molecule inhibitors of RNA-modifying enzymes
STORM Therapeutics is a clinical-stage biotechnology company pioneering the field of RNA epigenetics, developing small molecule inhibitors of RNA-modifying enzymes as a new class…
In vivo cell reprogramming therapies for degenerative disease
Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic…
Microplate consumables and instruments for life science laboratories
Porvair Sciences is a manufacturer of microplates, sample preparation consumables, and laboratory instruments for the life science and biotechnology industries. The company…
Targeted therapies against extrachromosomal DNA in cancer
Econic Biosciences is a drug discovery biotech developing therapies that target extrachromosomal DNA, a circular form of DNA found outside normal chromosomes that drives oncogene…
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and…
Novel methylation amplification platform for clinical genomic diagnostics
Syndex Bio is a Cambridge-based biotechnology company developing a proprietary platform technology that enables amplification of DNA methylation for the first time. Unlike…
Clinical-stage biotech developing treatments for multiple myeloma
CellCentric is a clinical-stage biopharmaceutical company developing inobrodib, a first-in-class oral inhibitor of the p300/CBP transcription co-activation proteins, for relapsed…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary…
Distributor of antibodies and reagents for life science research
Stratech Scientific is a UK distributor of life science research tools, supplying antibodies, reagents, cells, and specialist research products to laboratories across the UK and…